Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure (Q48512211)

12 February 2018

title

Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure (English)

1 reference

12 February 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

Nakamura M

1 reference

12 February 2018

Arakawa N

1 reference

12 February 2018

Yoshida H

1 reference

12 February 2018

Makita S

1 reference

12 February 2018

Niinuma H

1 reference

12 February 2018

Hiramori K

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

12 February 2018

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

American Heart Journal

1 reference

12 February 2018

volume

135

1 reference

12 February 2018

issue

1 reference

12 February 2018

page(s)

414-420

1 reference

12 February 2018

A new natriuretic peptide in porcine brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Atrial natriuretic peptide elevation in congestive heart failure in the human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Brain natriuretic peptide administered to man: actions and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Biological effects of rat iso-atrial natriuretic peptide and brain natriuretic peptide are indistinguishable from each other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970316-3

10.1016/S0002-8703(98)70316-3

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018